Workflow
TMMT(300334)
icon
Search documents
津膜科技(300334) - 2020 Q1 - 季度财报
2020-06-08 16:00
Financial Performance - Total revenue for Q1 2020 was ¥49,559,598.84, a decrease of 47.04% compared to ¥93,573,459.78 in the same period last year[7]. - Net profit attributable to shareholders was -¥45,891,064.40, representing a decline of 107.78% from -¥22,085,893.54 year-on-year[7]. - Basic and diluted earnings per share were both -¥0.15, a decrease of 114.29% from -¥0.07 in the same period last year[7]. - The company reported a net loss attributable to shareholders of approximately ¥45,891,100.00 for the first quarter[28]. - The net loss for Q1 2020 was ¥46,902,980.02, compared to a net loss of ¥21,192,250.10 in Q1 2019, representing a 121% increase in losses[65]. - The company's gross profit margin decreased significantly, with a gross profit of -¥21,251,978.59 for Q1 2020 compared to a gross profit of ¥32,781,763.21 in Q1 2019[65]. - The total comprehensive loss for Q1 2020 was ¥46,902,980.02, compared to a comprehensive loss of ¥21,192,250.10 in Q1 2019[66]. Cash Flow - Net cash flow from operating activities increased by 304.23% to ¥56,060,159.43, compared to -¥27,450,073.22 in the previous year[7]. - Cash flow from operating activities was ¥95,722,132.99 in Q1 2020, a decrease from ¥198,988,413.25 in the previous year[72]. - The total cash inflow from operating activities was ¥129,492,771.25, while cash outflow was ¥73,432,611.82, resulting in a net cash inflow[73]. - The company reported a net cash outflow from investing activities of ¥5,022,268.95, compared to a net outflow of ¥61,459,382.10 in the previous year[74]. - Cash inflow from financing activities was ¥146,768,884.00, while cash outflow was ¥190,302,944.30, leading to a net cash outflow of ¥43,534,060.30[74]. - The ending balance of cash and cash equivalents was ¥100,738,903.00, an increase from the beginning balance of ¥93,238,396.29[74]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,992,124,955.25, down 1.41% from ¥2,020,568,158.97 at the end of the previous year[7]. - Long-term borrowings increased by 100.67% to ¥150,845,000.00, primarily due to new bank loans received by subsidiaries[25]. - Total liabilities increased from CNY 1,111,780,507.78 to CNY 1,130,240,284.08, an increase of about 1.5%[58]. - Owner's equity decreased from CNY 908,787,651.19 to CNY 861,884,671.17, a decline of approximately 5.2%[59]. - The total amount from the top five suppliers decreased from CNY 19.97 million to CNY 10.16 million[33]. - The total amount from the top five customers decreased from CNY 69.81 million to CNY 34.17 million[33]. Operational Performance - Operating revenue decreased by 47.04% to ¥49,559,598.84 compared to the same period last year, primarily due to the impact of COVID-19 on main business operations and a significant reduction in sales orders for membrane products[16]. - Operating costs decreased by 44.97% to ¥33,456,271.85, attributed to a reduction in orders and corresponding decrease in procurement[17]. - Sales expenses decreased by 57.11% to ¥4,998,251.92, mainly due to reductions in salaries for sales personnel and transportation costs[17]. - Research and development expenses for Q1 2020 were ¥10,742,406.12, a decrease of 27% from ¥14,756,982.05 in the previous year[63]. - The company is focusing on developing new products and optimizing market structure to recover from the impact of the pandemic[33]. Government Support and Subsidies - The company received government subsidies amounting to ¥1,903,134.63 during the reporting period[8]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,100[11]. - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., held 21.19% of the shares, totaling 64,004,465 shares[11]. - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12]. Research and Development - The company completed the development of high-efficiency oil-water separation materials and components, which are expected to enhance its membrane technology applications[31]. - The company has developed two types of membrane materials for seawater desalination, aiming for low-cost, high-efficiency, and long-lifespan products[31]. - The company is conducting research on energy-saving integrated pressure membrane filtration equipment, enhancing the performance of its SMF and CMF products[31]. - The company has completed the development of a high-efficiency MBR integrated device for urban black and odorous water treatment, expanding its application market[31]. - The company is preparing for the acceptance of a project focused on near-zero discharge of coal conversion wastewater, enhancing its market competitiveness in this area[31]. - The company is expanding its market presence through the development of new technologies and products in the environmental protection sector[31]. Strategic Changes - The company is in the process of changing its actual controller, planning to introduce a strategic investor to acquire at least 51% of the controlling shareholder's equity[46]. - The company is planning to transfer 52.25% of its stake in the subsidiary Yichun Jinhua to optimize its asset structure and reduce operational risks[42]. - The company has undertaken a guarantee for Gansu Jinqiao Water Technology Group's loan of RMB 54.68 million with a term of 10 to 15 years at an interest rate of 5.15% to 5.44%[40].
津膜科技(300334) - 2019 Q4 - 年度财报
2020-05-07 16:00
Financial Performance - The company's operating revenue for 2019 was ¥516,341,745.16, a decrease of 24.77% compared to ¥686,359,697.96 in 2018[23]. - The net profit attributable to shareholders was -¥833,095,593.05, representing a decline of 7,125.95% from a profit of ¥11,857,416.70 in the previous year[23]. - The total assets at the end of 2019 were ¥2,020,568,158.97, down 31.84% from ¥2,964,451,122.08 in 2018[23]. - The net assets attributable to shareholders decreased by 50.43% to ¥832,482,436.67 from ¥1,679,446,069.17 in 2018[23]. - The company reported a basic and diluted earnings per share of -¥2.750, a decrease of 6,975.00% from ¥0.040 in 2018[23]. - The total profit for 2019 was CNY -823,210,081.12, representing a decline of 4,726.24% compared to the previous year[43]. - The company reported a net profit margin of 12%, which is an improvement from 10% in the previous year[106]. Accounts Receivable and Management - The company reported a significant increase in accounts receivable due to the long implementation cycle of membrane engineering projects, leading to a growing trend in absolute value[7]. - The company has established a strict accounts receivable management system and has made adequate provisions for bad debts in accordance with relevant accounting standards[7]. - The company faced liquidity issues due to a high volume of accounts receivable and slow project progress, prompting efforts to recover outstanding payments[48]. - Accounts receivable increased to ¥317,831,260.31, representing 15.73% of total assets, up from 14.48% at the beginning of the year, an increase of 1.25%[73]. Research and Development - The company has achieved a leading position in domestic membrane technology, with its ultrafiltration and microfiltration membranes reaching international advanced levels[9]. - The company has developed hundreds of patents and non-patent technologies, breaking the long-standing technological monopoly of developed countries[9]. - The company completed five research projects in 2019, including two national-level projects and three provincial-level projects[47]. - The company applied for 47 new patents in 2019, including 23 invention patents[47]. - Research and development expenses increased by 3.82% from ¥62,809,725.60 in 2018 to ¥65,207,624.59 in 2019[63]. - The company is developing large-scale equipment for seawater desalination and comprehensive utilization of water resources[65]. - The company has completed the development of high-efficiency oil-water separation materials and equipment for emergency response to thin oil films and hazardous materials[64]. Revenue and Sales - Revenue from water treatment engineering dropped by 43.05% to ¥246,996,519.23, down from ¥433,672,874.89 in the previous year[52]. - Sales of membrane products increased by 19.43% to ¥151,813,492.44, compared to ¥127,111,552.38 in 2018[52]. - Domestic revenue accounted for 98.04% of total revenue, totaling ¥506,247,162.38, which is a 25.35% decrease from the previous year[52]. - The company reported a significant increase in non-operating income from government subsidies amounting to ¥11,251,853.91 in 2019[29]. Corporate Governance and Restructuring - The company has established a complete corporate governance structure in compliance with the Company Law and Securities Law, ensuring no adverse effects from the restructuring[98]. - The actual controller, Tianjin University, commits to avoiding any direct or indirect competition with Tianjin Membrane Technology's main business post-restructuring[98]. - The restructuring is expected to strengthen the company's governance and operational independence, benefiting its overall strategic direction[98]. - The company has committed to maintaining independence in business, assets, finance, personnel, and institutions from Tianjin University and its affiliates[98]. Financial Instruments and Standards - The company has implemented new financial instrument standards effective from January 1, 2019, which require a shift to an expected credit loss model for impairment[113]. - The new financial instrument standards classify financial assets into three categories based on their cash flow characteristics and management business model[113]. - The impairment provision for accounts receivable increased from CNY 74,270,153.52 to CNY 75,179,677.04 due to remeasurement adjustments[119]. Environmental and Social Responsibility - The company has completed the construction of pollution prevention facilities, which are operating normally, and has reported the temporary suspension of wastewater treatment facilities to the ecological environment bureau[152][153]. - The company has established an emergency response plan for environmental incidents, which was filed with the Tianjin Economic and Technological Development Zone Environmental Supervision Team on May 29, 2019[155]. - The company conducts regular monitoring of wastewater discharge parameters through a third-party testing service[156]. Future Outlook and Strategy - The company aims to enhance its market competitiveness by increasing marketing efforts and expanding external collaborations to drive significant growth in membrane product sales in 2020[87]. - The strategic focus for 2020 includes concentrating on membrane system integration projects, particularly in municipal water supply and wastewater reuse sectors[88]. - The overall industry outlook is positive, driven by increasing government support and policies aimed at water resource protection and pollution control, creating a favorable environment for growth[86].
津膜科技(300334) - 2019 Q4 - 年度财报
2020-04-28 16:00
Financial Performance - The company's operating revenue for 2019 was ¥516,341,745.16, a decrease of 24.77% compared to ¥686,359,697.96 in 2018[22]. - The net profit attributable to shareholders was -¥833,095,593.05, representing a decline of 7,125.95% from a profit of ¥11,857,416.70 in the previous year[22]. - The total profit for 2019 was CNY -823,210,081.12, representing a decline of 4,726.24% compared to the previous year[42]. - The company's equity assets increased by CNY 36,794,800, a year-on-year growth of 54.80% due to profit growth from joint ventures[35]. - The company reported a basic and diluted earnings per share of -¥2.750, a decrease of 6,975.00% from ¥0.040 in 2018[22]. - The weighted average return on net assets was -65.97%, down 66.69% from 0.72% in the previous year[22]. - The company reported a net profit of -833,095,593.05 CNY for 2019, representing a significant decline compared to a profit of 11,857,416.70 CNY in 2018[96]. Revenue and Sales - Revenue from water treatment engineering dropped by 43.05% to ¥246,996,519.23, down from ¥433,672,874.89 in the previous year[51]. - Sales of membrane products increased by 19.43% to ¥151,813,492.44, compared to ¥127,111,552.38 in 2018[51]. - Domestic revenue accounted for 98.04% of total revenue, totaling ¥506,247,162.38, a decrease of 25.35% from the previous year[51]. - The company aims to enhance its market competitiveness by increasing marketing efforts and expanding external collaborations to boost membrane product sales significantly in 2020[86]. - The company plans to focus on membrane system integration projects, particularly in municipal water supply and wastewater reuse, to maintain contract growth and stable operational scale[87]. Research and Development - The company has developed hundreds of patents and non-patent technologies, achieving domestic leading and internationally advanced levels in ultrafiltration and microfiltration membrane products[8]. - Research and development expenses increased by CNY 1,702,600, a growth of 80.93% year-on-year, driven by internal development expenditures for seawater utilization projects[36]. - The company's R&D investment in 2019 amounted to approximately ¥65.21 million, representing 12.63% of total revenue, an increase from 9.15% in 2018[66]. - The company is developing two types of membrane materials for seawater desalination and comprehensive utilization, aiming to enhance domestic membrane product industrialization[64]. - The company has completed the development of high-efficiency oil-water separation materials and equipment for emergency response to oil spills[63]. Competition and Market Environment - The company faces intensified competition from international firms entering the Chinese market, prompting increased R&D investment and market expansion efforts[5]. - The water treatment industry is expected to experience rapid growth due to increasing government support and policies aimed at addressing water resource shortages and pollution[85]. - The company is committed to maintaining its competitive edge in the membrane technology sector through continuous innovation and strategic initiatives[5]. Asset Management and Financial Health - The total assets at the end of 2019 were ¥2,020,568,158.97, down 31.84% from ¥2,964,451,122.08 in 2018[22]. - The net assets attributable to shareholders decreased by 50.43% to ¥832,482,436.67 from ¥1,679,446,069.17 in 2018[22]. - The company has implemented strict accounts receivable management policies and established a dedicated team to address large or overdue receivables[6]. - The company is focusing on improving financial and capital management to enhance asset liquidity and quality amid challenging external economic conditions[47]. - The company has reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the year, representing a growth of 15% compared to the previous year[104]. Shareholder and Governance Issues - The board approved a profit distribution plan, proposing no cash dividends or bonus shares for shareholders, with a base of 302,065,356 shares[9]. - The company has not distributed any cash dividends or stock bonuses in the past three years, including the current reporting period[93]. - The company has commitments related to performance guarantees, with net profit commitments for the target company set at no less than 25 million CNY, 32.5 million CNY, and 42.25 million CNY for the years 2016, 2017, and 2018 respectively[96]. - The restructuring will enhance the governance mechanism of Tianjin Membrane Technology Co., Ltd., increasing its independence and aligning with the interests of all shareholders[97]. - The company has committed to maintaining independence in business, assets, finance, personnel, and institutions post-restructuring[97]. Legal and Compliance Matters - The company has ongoing litigation involving a construction contract dispute with Wangneng Environment Co., Ltd., with an involved amount of RMB 17.30 million[131]. - Another litigation regarding a loan dispute with Jiangsu Mountain Spring Membrane Environmental Engineering Technology Co., Ltd. has an involved amount of RMB 24.43 million, which is currently awaiting trial[132]. - The company has not faced any situations that could lead to suspension or termination of listing[130]. - There are no significant penalties or rectification measures applicable to the company during the reporting period[133]. Future Outlook and Strategic Initiatives - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 12%[104]. - New product development includes the launch of a next-generation membrane technology, expected to enhance efficiency by 25%[105]. - The company is investing 100 million RMB in R&D for innovative membrane solutions over the next three years[104]. - The company is considering strategic acquisitions to bolster its technology portfolio, with a budget of $100 million allocated for potential deals[199]. - Future outlook remains positive, with a focus on innovation and market leadership in the industry[200].
津膜科技(300334) - 2020 Q1 - 季度财报
2020-04-28 16:00
Financial Performance - Total revenue for Q1 2020 was ¥49,559,598.84, a decrease of 47.04% compared to ¥93,573,459.78 in the same period last year[9] - Net profit attributable to shareholders was -¥86,702,793.59, representing a decline of 292.57% from -¥22,085,893.54 year-on-year[9] - Basic and diluted earnings per share were both -¥0.287, a decrease of 314.29% from -¥0.07 in the same period last year[9] - The company's operating revenue decreased by 47.04% year-on-year, amounting to approximately 495.60 million, primarily due to the impact of COVID-19 on main business operations and a significant reduction in sales orders for membrane products[18] - The company reported a net loss attributable to shareholders of approximately 86.70 million for the first quarter, largely due to increased bad debt provisions[30] - The net loss for Q1 2020 was ¥87,714,709.21, compared to a net loss of ¥21,192,250.10 in Q1 2019, representing a significant increase in losses[65] Cash Flow and Assets - Net cash flow from operating activities improved to ¥56,060,159.43, a significant increase of 304.23% compared to -¥27,450,073.22 in the previous year[9] - Cash flow from operating activities was ¥95,722,132.99 in Q1 2020, down 52% from ¥198,988,413.25 in the previous year[71] - The company reported a total cash and cash equivalents balance of ¥100,738,903.00 at the end of Q1 2020, compared to ¥191,689,272.80 at the end of Q1 2019[74] - Total assets at the end of the reporting period were ¥1,951,313,226.06, down 3.43% from ¥2,020,568,158.97 at the end of the previous year[9] - Accounts receivable increased by 393.33% year-on-year, totaling approximately 72.55 million, mainly due to an increase in bank acceptance bills received[25] - The total amount of non-operating funds occupied by related parties is ¥2,146.78 million, which accounts for 2.88% of the latest audited net assets[51] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,100[12] - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., held 21.19% of the shares[12] - There were no significant changes in the shareholding structure or any repurchase transactions among the top shareholders during the reporting period[13] Government Support and Subsidies - The company received government subsidies amounting to ¥1,903,134.63 during the reporting period[10] - The company recorded a significant increase in other income, which rose by 287.10% year-on-year to approximately 19.03 million, primarily due to government subsidies[21] Research and Development - The company has applied for 59 patents, including 27 new patents, to protect core technologies and enhance market competitiveness[33] - The company is developing a new gravity-driven submerged ultrafiltration system, which significantly reduces operational energy consumption and land area[33] - The company is conducting research on energy-saving integrated pressure membrane filtration equipment to improve the performance of ultrafiltration membranes[32] Operational Changes and Strategies - The company is facing intensified competition from international firms, prompting increased R&D investment and market expansion efforts[36] - The company is focusing on talent retention and development to address human resource risks, ensuring a stable workforce for future growth[37] - The company has implemented strict accounts receivable management to mitigate risks associated with expanding business scale[36] Litigation and Legal Matters - The company is involved in litigation with Jiangsu Mountain Spring Jinmo Environmental Engineering Co., Ltd. regarding a loan dispute, with an outstanding amount of ¥2,146.78 million[51] - The company reported no violations regarding external guarantees during the reporting period[49] - The company received a court ruling regarding a contract dispute with Ordos City Water Affairs Co., Ltd., which is currently under appeal[47] Financial Liabilities - The company's long-term borrowings increased by 100.67% year-on-year, amounting to approximately 1.51 billion, as a result of new bank loans received[27] - Total liabilities increased from CNY 1,111,780,507.78 to CNY 1,130,240,284.08, an increase of about 1.0%[59] - Owner's equity decreased from CNY 908,787,651.19 to CNY 821,072,941.98, a decline of approximately 9.6%[60]
津膜科技(300334) - 2019 Q3 - 季度财报
2019-10-24 16:00
Financial Performance - Net profit attributable to shareholders was CNY -87,144,898.71, representing a significant decline of 42,286.16% year-on-year[7]. - Operating revenue for the reporting period was CNY 125,407,097.28, an increase of 0.47% compared to the same period last year[7]. - Basic earnings per share were CNY -0.29, reflecting a decrease of 41,528.57% compared to the same period last year[7]. - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses of CNY -86,717,696.62, a decline of 2,104.19% year-on-year[7]. - The net profit for the period was -102.78 million yuan, representing a year-on-year decline of 1,294.59%[18]. - The net profit for Q3 2019 was a loss of CNY 85,920,734.20, compared to a profit of CNY 1,590,721.70 in the previous year, indicating a substantial decline[55]. - The company reported a net loss of CNY 108,640,179.55 for Q3 2019, compared to a net loss of CNY 30,761,824.61 in the same period last year, indicating a significant increase in losses[66]. - The comprehensive income total for Q3 2019 was a loss of ¥102,777,965.46, compared to a gain of ¥8,603,605.12 in the previous year[63]. Cash Flow - The net cash flow from operating activities was CNY 38,502,068.00, showing a substantial increase of 363.51% year-on-year[7]. - The company experienced a net cash inflow from operating activities of CNY 38,502,068.00, a recovery from a net outflow of CNY -14,611,433.84 in the same quarter last year[70]. - Total cash inflow from operating activities reached 451,056,059.70 CNY, up from 324,661,679.77 CNY year-over-year, indicating a growth of approximately 38.9%[74]. - The net cash flow from investing activities was -61,370,008.52 CNY, an improvement from -103,266,364.00 CNY year-over-year[75]. - The net cash flow from financing activities was -9,880,722.43 CNY, compared to a positive net flow of 14,093,461.45 CNY in the previous year[75]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,706,628,206.76, a decrease of 8.70% compared to the end of the previous year[7]. - The company's total liabilities decreased to CNY 1,056,221,926.66 from CNY 1,206,776,260.91, a reduction of about 12.4%[46]. - The company's equity attributable to shareholders decreased to CNY 1,563,112,617.73 from CNY 1,679,446,069.17, a decline of approximately 6.9%[47]. - The company's cash and cash equivalents decreased to CNY 201,472,177.92 from CNY 271,340,871.89, representing a decline of approximately 25.7%[44]. - The company's total liabilities decreased to CNY 822,404,960.56 from CNY 900,518,655.45, reflecting a decline of about 8.68%[52]. Shareholder Information - The total number of shareholders at the end of the reporting period was 22,929[11]. - The top three shareholders held a combined 44.24% of the shares, with Tianjin Membrane Engineering Technology Co., Ltd. holding 21.19%[11]. Operational Costs and Expenses - Total operating costs increased significantly to CNY 167,664,380.45 from CNY 123,957,421.99, marking an increase of about 35.3%[54]. - Management expenses rose by 18.07 million yuan, a 38.29% increase year-on-year, primarily due to new litigation-related provisions[19]. - Asset impairment losses surged by 49.44 million yuan, up 664.44% year-on-year, attributed to increased bad debt and inventory write-down provisions[19]. - Financial expenses increased to CNY 28,588,836.75, compared to CNY 23,530,216.72 in the previous year, with interest expenses rising to CNY 25,926,663.80 from CNY 18,371,330.28[66]. Investment Income - Investment income increased by 6.85 million yuan, a 149.16% rise year-on-year, due to profits from joint ventures[20]. - The company reported an investment income of CNY 2,945,340.08, an increase from CNY 1,716,174.87 in the previous year, showing a growth of approximately 71.7%[54]. - The company reported an investment income of ¥11,440,459.77 for the year-to-date period, up from ¥4,591,634.84 in the same period last year[60]. Future Outlook - The company anticipates a significant decline in overall revenue and gross profit due to delays in project construction and increased costs, leading to potential losses for the year[36].
津膜科技(300334) - 2019 Q2 - 季度财报
2019-08-22 16:00
Financial Performance - Total revenue for the reporting period was ¥243,695,274.54, a decrease of 28.93% compared to the same period last year[20]. - Net profit attributable to shareholders was -¥16,896,337.13, representing a decline of 441.23% year-over-year[20]. - Net cash flow from operating activities improved to ¥79,215,539.45, an increase of 242.34% compared to the previous year[20]. - Total assets at the end of the reporting period were ¥2,837,851,204.58, down 4.27% from the end of the previous year[20]. - The company reported a basic and diluted earnings per share of -¥0.056, a decrease of 380.00% year-over-year[20]. - The weighted average return on net assets was -1.01%, down 1.31% from the previous year[20]. - The total profit for the same period was -RMB 15,344,171.11, representing a decline of 259.88% year-on-year[40]. - The net profit attributable to the parent company was -RMB 16,896,337.13, down 441.23% year-on-year[40]. - The company reported a total comprehensive income of -12,951.6 million RMB for the current period[173]. Research and Development - The company has developed hundreds of patents and non-patent technologies, achieving domestic leading and internationally advanced levels in ultrafiltration and microfiltration membrane products[7]. - The company plans to increase R&D investment and market expansion efforts to enhance competitiveness amid intensifying industry competition[4]. - Research and development investment amounted to RMB 26,747,767.81, a decrease of 14.14% compared to the previous year[43]. - The company aims to enhance its core competitiveness through continuous technological innovation and the integration of resources from national research platforms[41]. - The company has established a comprehensive training program and competitive promotion mechanisms to attract and retain high-quality talent, addressing potential human resource risks[71]. Accounts Receivable and Management - The company reported a significant increase in accounts receivable due to the long implementation cycle of membrane engineering projects, leading to a growing trend in absolute value[4]. - The company has established strict accounts receivable management systems and has set up a dedicated team to address large or overdue receivables[4]. - Accounts receivable increased to RMB 363,351,945.13, representing 12.80% of total assets, compared to 12.01% in the previous year[51]. - Accounts receivable are expected to grow due to the long implementation cycles of membrane engineering projects, leading the company to implement strict management measures[70]. Investment and Assets - Long-term equity investments increased by ¥14,095,100, a growth of 20.99% compared to the beginning of the period[32]. - Fixed assets decreased by ¥7,787,700, a decline of 2.66% compared to the beginning of the period[32]. - The company reported an investment income of RMB 8,495,119.69, which accounted for -55.36% of total profit, primarily from its investment in Tianjin Ruide Sain Water Industry Co., Ltd.[48]. - The company's long-term equity investments increased to RMB 81,239,475.41, accounting for 2.86% of total assets, up from 2.27% in the previous year[51]. - The total amount of non-equity investments during the reporting period reached CNY 13,445,000, with cumulative actual investment of CNY 95,690,000[58]. Cash Flow and Financing - The company reported a significant increase in cash flow from operating activities, totaling RMB 79,215,539.45, a 242.34% increase due to higher sales collections[43]. - The company reported a net cash outflow from investing activities of CNY -61,354,448.52 for the first half of 2019, compared to a larger outflow of CNY -102,906,778.00 in the same period of 2018, showing a reduction in investment expenditures[160]. - Cash inflow from financing activities was CNY 299,853,936.32 in the first half of 2019, down from CNY 431,165,494.20 in the first half of 2018, representing a decrease of approximately 30.5%[160]. - The net cash flow from financing activities for the first half of 2019 was CNY 18,744,435.44, a decline from CNY 91,981,697.61 in the same period of 2018, indicating reduced financing activities[160]. Shareholder and Equity Structure - The total number of shares is 303,922,186, with 90.43% being tradable shares[114]. - Major shareholders include Tianjin Membrane Engineering Technology Co., Ltd. holding 21.06% (64,004,465 shares) and High-tech Investment Development Co., Ltd. holding 12.02% (36,540,000 shares)[121]. - The company has a diverse shareholder base, including state-owned enterprises and foreign entities, which may enhance its market stability[121]. - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, indicating concentrated ownership[121]. - The company has not reported any changes in the number of shares held by major shareholders during the reporting period, suggesting stability in ownership[121]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[98]. - The company discharged a total of 2.1 tons of chemical oxygen demand (COD) with a concentration of 58 mg/L, complying with the discharge standards[99]. - The company reported a total of 808 tons of COD and 367.67 tons of biochemical oxygen demand (BOD) from its subsidiary, with no violations of discharge standards[99]. - All pollution prevention facilities of Dongying Jinmo Environmental Technology Co., Ltd. have been completed and are operating normally[101]. Governance and Compliance - The company has established a governance structure including a shareholders' meeting, board of directors, and supervisory board[177]. - The financial report is prepared in accordance with the accounting standards issued by the Ministry of Finance[181]. - The company emphasizes continuous operation as the basis for its financial reporting[182]. - The company has not engaged in any mergers or acquisitions during the reporting period[95]. - The company complied with all commitments made regarding shareholding and did not violate any regulations[79].
津膜科技(300334) - 2019 Q1 - 季度财报
2019-04-28 16:00
Financial Performance - Total revenue for Q1 2019 was ¥93,573,459.78, a decrease of 38.44% compared to ¥152,011,809.46 in the same period last year[7] - Net profit attributable to shareholders was -¥22,085,893.54, representing a decline of 813.30% from -¥2,418,262.53 year-on-year[7] - Basic and diluted earnings per share were both -¥0.07, a decrease of 775.00% compared to -¥0.008 in the same period last year[7] - The company's operating revenue for the reporting period was 93.57 million yuan, a decrease of 38.44% compared to the same period last year, primarily due to delays in project construction progress and unrecognized revenue from projects won at the end of 2018[27] - The company reported a significant increase in revenue for Q1 2019, with a year-over-year growth of 15%[46] - The company reported a significant increase in revenue for Q1 2019, with total revenue reaching 150 million RMB, representing a 20% year-over-year growth[52] Cash Flow and Assets - Net cash flow from operating activities was -¥27,450,073.22, down 59.78% from -¥17,180,446.18 in the previous year[7] - The balance of financial assets measured at fair value and recorded in current profit and loss decreased by 14.20 million yuan, a 100% reduction, due to the implementation of new accounting standards[24] - The net cash flow from operating activities for the reporting period was -27.45 million yuan, a decrease of 59.78% compared to the same period last year, mainly due to increased cash payments for goods and services and higher taxes paid[26] - As of March 31, 2019, the company's cash and cash equivalents decreased to ¥198,992,185.16 from ¥271,340,871.89 at the end of 2018, representing a decline of approximately 26.7%[63] - Cash and cash equivalents decreased from CNY 173,205,399.35 to CNY 131,406,744.38, a decrease of approximately 24.1%[68] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,853[11] - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., held 21.06% of shares, totaling 64,004,465 shares[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Research and Development - R&D expenses were CNY 14,756,982.05, a reduction of 44.46% compared to CNY 26,566,954.47 in the previous year[20] - The company has ongoing research and development projects aimed at enhancing oil-water separation technology and seawater desalination, which are expected to expand the application of the company's membrane technology[29] - The company is developing a high-performance hollow fiber nanofiltration membrane with independent intellectual property rights, aiming to break foreign monopolies and extend the membrane technology industry chain[30] - The company is investing in R&D, with a budget increase of 25% for new technology development in 2019[46] Market Expansion and Strategy - The company plans to increase R&D investment and enhance market expansion to maintain its competitive edge amid intensifying industry competition[34] - Market expansion plans include entering two new international markets by the end of Q3 2019[50] - The company is considering strategic acquisitions to enhance its market position, with a focus on complementary technologies[50] - A strategic acquisition of a local competitor is in progress, which is expected to increase the company's production capacity by 40%[48] Corporate Governance and Compliance - The company has established a sound corporate governance structure in accordance with the Company Law and Securities Law, ensuring no adverse impact from the restructuring[44] - The actual controller of the company committed to avoiding any illegal occupation of the company's funds and assets[43] - The company has committed to ensuring that related transactions are conducted fairly and in accordance with legal regulations[54] - The company has not reported any major illegal activities since its establishment, maintaining compliance with relevant laws and regulations[54] Liabilities and Financial Obligations - The company has provided guarantees for loans totaling CNY 54.68 million and CNY 10 million for its subsidiaries to support their funding needs[38][39] - The total amount of non-operating funds occupied by major shareholders and related parties was ¥2,188.8 million, which accounted for 1.30% of the latest audited net assets[57] - The company is currently in communication with Jiangsu Mountain Spring Membrane Environment Engineering Technology Co., Ltd. regarding the repayment of a loan of ¥19.2 million, which was borrowed for three years at an interest rate of 7%[57] Operational Efficiency - The company aims to reduce operational costs by 10% through efficiency improvements in the supply chain[50] - The company has set a target to reduce operational costs by 15% over the next year through efficiency improvements and process optimization[52]
津膜科技(300334) - 2018 Q4 - 年度财报
2019-04-28 16:00
Financial Performance - The company's operating revenue for 2018 was approximately ¥686.36 million, representing an increase of 8.41% compared to ¥633.12 million in 2017[22]. - The net profit attributable to shareholders for 2018 was approximately ¥11.86 million, a significant turnaround from a loss of ¥66.57 million in 2017, marking a 117.81% improvement[22]. - The net cash flow from operating activities for 2018 was approximately ¥27.31 million, compared to a negative cash flow of ¥72.18 million in 2017, reflecting a 137.84% increase[22]. - The total assets at the end of 2018 amounted to approximately ¥2.96 billion, a 1.57% increase from ¥2.92 billion at the end of 2017[22]. - The company reported a basic earnings per share of ¥0.04 for 2018, compared to a loss of ¥0.24 per share in 2017, indicating a 116.67% improvement[22]. - The total profit for 2018 was CNY 17,794,377.10, representing a year-on-year increase of 123.36%[44]. - The net profit attributable to the parent company was CNY 11,857,416.70, up 117.81% compared to the previous year[44]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year, representing a year-over-year growth of 15%[119]. Research and Development - The company has developed hundreds of patents and proprietary technologies, achieving domestic leadership and international advanced levels in ultrafiltration and microfiltration membrane products[8]. - The company is focused on enhancing production automation and green production practices, leading to reduced unit costs[51]. - The company invested CNY 62,809,725.60 in R&D in 2018, accounting for 9.15% of its operating revenue[69]. - The number of R&D personnel increased to 239 in 2018, representing 34.89% of the total workforce[69]. - The company has made advancements in R&D, including the development of new membrane products and processes, such as the MABR hollow fiber membrane[51]. - The company is developing a large-scale ultrafiltration system with a capacity of 20,000 tons per day for seawater desalination, which is expected to enhance market competitiveness[66]. - New product development includes the launch of a cutting-edge filtration technology expected to enhance market competitiveness[115]. - The company is exploring potential acquisitions to enhance its technology portfolio and market reach, with a budget of 500 million RMB allocated for this purpose[119]. Market Strategy and Competition - The company faces intensified competition from international firms, prompting increased R&D investment and market expansion efforts to maintain its competitive edge[4]. - The company has established partnerships with several environmental engineering firms to enhance market channels and resource sharing[44]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[115]. - A strategic acquisition of a smaller competitor was completed, which is anticipated to contribute an additional 200 million RMB in annual revenue[115]. - The company is currently developing integrated wastewater treatment devices for the chemical industry to address high costs and large land requirements[68]. Talent Management - The company emphasizes talent retention and development, implementing measures to enhance compensation and training for core personnel to mitigate the risk of talent loss[7]. - The company is committed to maintaining confidentiality and loyalty among its R&D staff through strict confidentiality agreements and competitive incentives[8]. - The company emphasizes the importance of talent management and corporate culture to enhance its competitive edge[104]. - The company conducts regular environmental monitoring, including COD and ammonia nitrogen, to ensure compliance with environmental standards[176]. Corporate Governance - The board approved a profit distribution plan, proposing no cash dividends or bonus shares, with a capital reserve conversion of 0 shares for every 10 shares held[9]. - The restructuring is expected to enhance the governance structure of Tianjin Membrane Technology Co., Ltd., ensuring its independence and protecting the interests of all shareholders[114]. - The company has established a complete corporate governance structure in compliance with the Company Law and Securities Law, which will not be adversely affected by the restructuring[114]. - The company has adhered to all commitments without any violations reported during the reporting period[124]. Environmental Commitment - The company provided membrane engineering solutions, focusing on wastewater treatment and water resource management, indicating a strategic emphasis on environmental services[32]. - The company has completed the construction of pollution prevention facilities, which are operating normally[170]. - The company emphasizes a multi-faceted talent incentive strategy to create a harmonious and inspiring work environment[166]. - The company is committed to providing high-quality membrane products and solutions, aiming for continuous value growth for shareholders, employees, and society[166]. Financial Management - The company reported a significant increase in government subsidies, totaling ¥11,929,231.18, which accounted for 67.04% of other income[75]. - The impairment loss on assets increased by 189.01%, amounting to ¥33,632,360.18, primarily due to provisions for bad debts[75]. - The company raised a total of 59.60 million RMB through a non-public offering, with a net amount of 50.97 million RMB after deducting issuance costs[90]. - The company has a loan of 19.2 million RMB from Jiangsu Mountain Spring, with a term of three years and an annual interest rate of 7%[133]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 12%[115]. - The company plans to significantly increase sales of membrane products and systems in 2019, improving overall gross margin and profitability[102]. - The company aims to improve operational efficiency by implementing new technologies, expecting a cost reduction of approximately 5% in the next fiscal year[117]. - Future guidance includes a focus on diversifying the product line, with at least three new products expected to launch in 2019[118].
津膜科技(300334) - 2018 Q3 - 季度财报
2018-10-28 16:00
Financial Performance - Operating revenue for the reporting period was CNY 124,819,662.89, down 28.52% year-on-year, while year-to-date revenue was CNY 467,708,111.89, a decrease of 12.63%[8]. - Net profit attributable to shareholders of the listed company was CNY 206,572.27, a significant decline of 99.06% year-on-year, but year-to-date net profit increased by 499.00% to CNY 5,158,102.98[8]. - The basic earnings per share for the reporting period was CNY 0.0007, down 99.13% year-on-year, while year-to-date earnings per share increased by 466.67% to CNY 0.017[8]. - The company reported a significant increase in revenue for Q3 2018, achieving a total of 1.5 billion RMB, representing a year-over-year growth of 25%[39]. - The company reported a net profit margin of 12% for Q3 2018, reflecting improved operational efficiency[33]. - The company reported a total comprehensive income of CNY 8,603,605.12 for the period, compared to CNY 2,748,383.31 in the previous period[64]. - The net profit for the third quarter was -30,761,824.61 CNY, compared to -4,655,075.65 CNY in the same period last year, indicating a significant decline in profitability[67]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,913,809,122.61, a decrease of 0.17% compared to the end of the previous year[8]. - The company's total liabilities decreased to CNY 1,163,358,933.42 from CNY 1,266,329,121.93, showing a decline of approximately 8.2%[48]. - The company's cash and cash equivalents decreased by 129.38 million yuan, down 33.90% year-on-year, mainly due to payments for project procurement and short-term loan repayments[20]. - The company's cash and cash equivalents decreased to CNY 252,321,055.25 from CNY 381,697,726.52, representing a decline of approximately 33.9%[46]. - Total current liabilities decreased to CNY 814,376,554.80 from CNY 1,017,789,578.37, a reduction of about 20%[48]. Shareholder Information - Net assets attributable to shareholders of the listed company increased by 3.67% to CNY 1,672,746,755.45[8]. - The total number of ordinary shareholders at the end of the reporting period was 25,511[12]. - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., held 21.06% of the shares[12]. Cash Flow - The net cash flow from operating activities for the year-to-date was CNY -14,611,433.84, an improvement of 85.58%[8]. - Cash flow from financing activities increased by 17.25 million yuan, up 172.47% year-on-year, due to cash raised from the acquisition of Jin Qiao Water Science[24]. - The cash flow from operating activities showed a decrease in cash inflow, totaling 541,640,894.88 CNY, down from 652,242,433.17 CNY year-over-year[68]. Management and Governance - The company appointed new senior management, including Mr. Fan Ning as General Manager and Mr. Hao Kai as Vice General Manager and CFO[26]. - The company reported a significant improvement in its governance structure following the completion of the restructuring, enhancing its independence and aligning with the interests of all shareholders[30]. - The company has committed to avoiding any form of competition with its controlling shareholder and related entities, ensuring no conflicts of interest arise[31]. Strategic Initiatives - The company has been actively expanding its market presence through strategic partnerships and acquisitions[26]. - The company plans to provide a maximum loan guarantee of RMB 27.5 million to its subsidiary, Yichun Nuclear, for a total loan amount of RMB 50 million[27]. - The company is focused on sustainability, with plans to invest 100 million CNY in eco-friendly technologies over the next three years[32]. Research and Development - Research and development expenses for Q3 2018 were CNY 12,897,411.00, down 28.06% from CNY 17,950,310.99 in the previous year[53]. - New product development includes the launch of a next-generation membrane technology, projected to increase efficiency by 30%[35]. - The company has allocated $5 million for R&D in new technologies for the upcoming fiscal year[34].
津膜科技(300334) - 2018 Q2 - 季度财报
2018-08-29 16:00
Financial Performance - Total revenue for the reporting period was CNY 342,888,449, a decrease of 4.93% compared to CNY 360,687,965 in the same period last year[20]. - Net profit attributable to shareholders was CNY 4,951,530, representing a significant increase of 123.36% from a loss of CNY 21,199,612 in the previous year[20]. - Net profit after deducting non-recurring gains and losses was CNY 2,862,779, an increase of 113.27% from a loss of CNY 21,577,918 in the same period last year[20]. - The net cash flow from operating activities improved to -CNY 55,653,202, a 74.16% improvement from -CNY 215,416,370 in the previous year[20]. - Basic earnings per share increased to CNY 0.02, compared to a loss of CNY 0.08 per share in the same period last year, marking a 125% improvement[20]. - The total profit for the period was CNY 9,597,287.49, representing a year-on-year increase of 150.81%[38]. - The company reported a net profit of 2,088,751.15 yuan from non-recurring gains and losses, after accounting for tax and minority interests[25]. - The company's operating revenue for the first half of 2018 was CNY 342,888,449, a decrease of 4.93% compared to the previous year[44]. - The operating cost for the same period was CNY 226,130,419, reflecting a decrease of 19.49% year-on-year[44]. - The gross profit margin improved to 34.05%, an increase of 11.93% compared to the previous year[44]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,852,598,332.10, a decrease of 2.27% from CNY 2,918,735,386.07 at the end of the previous year[20]. - The company's fixed assets decreased by 0.28%, while intangible assets increased by 2.34%, indicating a shift in asset composition[31]. - Cash and cash equivalents decreased by 34.47%, primarily due to repayment of short-term loans and due bills[31]. - The company's total liabilities decreased to CNY 1,133,658,864.61 from CNY 1,266,329,121.93, a reduction of approximately 10.5%[154]. - The company's equity increased to CNY 1,718,939,467.49 from CNY 1,652,406,264.14, marking a growth of about 4%[155]. Research and Development - The company plans to increase R&D investment and market expansion efforts to enhance competitiveness in the face of intensified industry competition[4]. - The company is focused on R&D in membrane technology, developing various filtration solutions and enhancing its core competitiveness[33]. - The company has allocated 100 million RMB for R&D in 2018, focusing on innovative membrane solutions[80]. - Research and development expenses amounted to CNY 31,153,150.16, a decrease of 6.66% year-on-year[42]. - The company has developed hundreds of patents and non-patent technologies, achieving domestic leadership and international advanced levels in the production of ultrafiltration and microfiltration membranes[71]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by 2020[80]. - A strategic acquisition of a local competitor is anticipated to be finalized by Q4 2018, which is expected to add 200 million RMB in annual revenue[81]. - The company is exploring potential mergers and acquisitions to enhance its competitive position, with a target of completing at least one acquisition by the end of 2018[83]. - The company is actively involved in the wastewater treatment sector, offering technical consulting and operational services to government and industrial clients[30]. - The company secured new orders worth CNY 16,486,820 in energy-saving and environmental protection projects during the reporting period[44]. Corporate Governance and Compliance - The company has established a complete corporate governance structure in compliance with relevant laws and regulations prior to the restructuring[77]. - The controlling entity will not engage in any illegal appropriation of the company's funds or assets[77]. - The company has committed to maintaining transparency and compliance with relevant regulations in its financial dealings[86]. - The company has established measures to protect its intellectual property and prioritize its own business interests[85]. - The company has committed to avoiding any business activities that may compete with its main operations, ensuring no conflicts of interest arise[79]. Shareholder Information - The total number of shares held by the director Ye Quan increased to 3,608,046 shares during the reporting period[142]. - The total number of ordinary shareholders at the end of the reporting period was 26,629[133]. - The largest shareholder, Tianjin Membrane Engineering Technology Co., Ltd., holds 21.06% of shares, totaling 64,004,465 shares[134]. - The company has a significant number of shares under lock-up agreements, indicating a commitment from major shareholders[130]. - The total amount of ordinary shares issued is CNY 276,037,707.00, remaining unchanged from the previous period[184]. Environmental and Social Responsibility - The company is committed to sustainability, with plans to reduce production waste by 30% over the next two years[83]. - The company reported no significant environmental incidents or violations in its pollution discharge[110]. - The company’s environmental monitoring includes regular testing of wastewater parameters such as COD, ammonia nitrogen, and total phosphorus, with monthly and quarterly assessments[112]. - The company has not yet initiated any targeted poverty alleviation programs as of the reporting period[114]. - The company has committed to sustainability initiatives, aiming for a 20% reduction in carbon emissions by 2025[84].